Concepedia

Author

Rudi Pauwels

Rega Institute for Medical Research

Also Known As

PAUWELS R, R PAUWELS, R Pauwels, R. PAUWELS, R. Pauwels, R.A. Pauwels, R.A.R. Pauwels, RUDI PAUWELS, Romain A. Pauwels, Romain Pauwels

196

Publications

18.1K

Citations

69

H-Index

67

Concepts

All Affiliations

Rega Institute for Medical ResearchKU LeuvenJanssen (Belgium)University of GroningenJanssen (United States)
RP

About

Rudi Pauwels is an author at Rega Institute for Medical Research specializing in medicine, hiv, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

51

76

11.8K

2

Biochemistry

23

25

2.9K

3

Natural Sciences

20

21

2.3K

4

Biomolecular Engineering

13

13

1.5K

5

Engineering

5

5

410

Rudi Pauwels

×

116

Publications

16.5K

Citations

66

H-Index

YearCitations

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

Rudi Pauwels, Jan Balzarini, Masanori Baba,

Journal of Virological Methods

1988

1.6K

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Rudi Pauwels, Koen Andries, Jan Desmyter,

Nature

1990

754

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

Masanori Baba, Robert Snoeck, Rudi Pauwels,

Antimicrobial Agents and Chemotherapy

1988

537

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

Erik De Clercq, Takashi Sakuma, Masanori Baba,

Antiviral Research

1987

512

Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants

Kalyan Das, Arthur D. Clark, Paul Lewi,

Journal of Medicinal Chemistry

2004

511

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

Masanori Baba, Rudi Pauwels, Jan Balzarini,

Proceedings of the National Academy of Sciences

1988

465

A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

Kurt Hertogs, Marie‐Pierre de Béthune, Veronica Miller,

Antimicrobial Agents and Chemotherapy

1998

391

Antiviral Effects of Plasma and Milk Proteins: Lactoferrin Shows Potent Activity against Both Human Immunodeficiency Virus and Human Cytomegalovirus Replication In Vitro

Martin C. Harmsen, P. J. Swart, M.-P. de Béthune,

The Journal of Infectious Diseases

1995

376

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates

Sandra De Meyer, Hilde Azijn, Dominique Surleraux,

Antimicrobial Agents and Chemotherapy

2005

354

Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro

Masanori Baba, Rudi Pauwels, Piet Herdewijn,

Biochemical and Biophysical Research Communications

1987

344

Page 1